Effect of P2Y12 inhibitors on MACE after CABG surgery - Ep 169

Dr. Arden Barry shares his team's findings from their large population database when evaluating the effect of exposure to P2Y12 inhibitors, versus no exposure, on the occurrence of major adverse cardiovascular events. The results support the use of P2Y12 inhibitors (primarily clopidogrel), in addition to other standard cardiovascular preventive therapy, in patients who undergo CABG surgery, but take a listen for all the details. Access the OPEN ACCESS manuscript here: https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/phar.70047

Om Podcasten

This podcast brings you interviews with journal authors providing insight on their recent publication in an official journal of the American College of Clinical Pharmacy. Pharmacotherapy publishes advances in human pharmacology and drug therapy and the JACCP publishes innovations in clinical pharmacy practice. ACCP JOURNALS DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIALS.